MacroGenics
MGNX
#9393
Rank
NZ$0.15 B
Marketcap
NZ$2.37
Share price
-0.72%
Change (1 day)
-58.85%
Change (1 year)

MacroGenics (MGNX) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$0.46 Billion

According to MacroGenics's latest financial reports the company's total assets are NZ$0.46 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

MacroGenics - Total assets on balance sheet (from 2012 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$0.46 B-1.68%
2023-12-31NZ$0.47 B6.82%
2022-12-31NZ$0.44 B-10%
2021-12-31NZ$0.49 B-6.5%
2020-12-31NZ$0.52 B13.12%
2019-12-31NZ$0.46 B-6.29%
2018-12-31NZ$0.49 B-5.95%
2017-12-31NZ$0.52 B17.16%
2016-12-31NZ$0.44 B-14.4%
2015-12-31NZ$0.52 B136.53%
2014-12-31NZ$0.22 B44.99%
2013-12-31NZ$0.15 B134.28%
2012-12-31NZ$65.33 M-18.65%
2011-12-31NZ$80.31 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Xencor
XNCR
NZ$1.50 B 220.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$361.31 B 76,989.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$224.24 B 47,744.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$101.32 B 21,517.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$156.03 B 33,191.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$198.95 B 42,348.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$167.71 B 35,683.69%๐Ÿ‡บ๐Ÿ‡ธ USA